돼지의 체세포 핵이식(Somatic cell nuclear transfer,SCNT)은 인간에게 약리적 효과가 있는 단백질, 이종 간 장기이식(xenotransplantation)에 사용되는 장기, 질병 연 구 목적의 모델 동물을 제공한다. 특히 형질전환 돼지를 활용한 심장 이식이 세계 최초로 성공한 후 형질전환 돼 지 생산의 안정화는 다음 연구를 위한 중요한 점으로 대 두되고 있으나, 미니돼지의 체세포 핵이식 배아의 생산 효율은 아직 낮은 실정이다. 형질전환의 성공은 양질의 SCNT 배아 생산에서 시작되어야 한다. 이러한 SCNT 배 아의 생산 효율을 향상할 수 있는 요인 중에는 공여 세포 의 형태가 있으며, 성공적인 공여 세포의 생산을 위해서 는 종축에 따른 세포의 특성을 파악하여야 하고, 혈액형 의 차이에서 발생하는 문제점 해결을 위해 OO 타입의 선 별이 필요하다. 본 연구에서는 지속적인 계대 배양을 통 하여 공여 세포로 사용되는 미니돼지의 태아섬유아세포의 계대 배양 조건을 확립하고자 한다. 또한 미니돼지의 혈 액형을 PCR 기반으로 분석하여 분류하고 OO 타입의 선 별을 통하여 이종 간 이식에 용이하게 공여 세포의 조건 을 확립하였다. 이후 sgRNA(single guide RNA)를 사용하 여 CRISPR-Cpf1로 GGTA1(α-1,3 galactosyl-transferase) 유전자를 knock-out 한 미니돼지의 생산으로, 급성면역반 응을 유발하는 Gal(1,3)Gal epitope이 제거된 미니돼지의 세포 주를 구축 및 체세포 핵이식을 통해 GGTA1 knock-out 미니돼지를 생산하였으며, 이러한 연구는 이후 체세포 핵이식 및 이종 간 장기이식에 중요한 기초자료로 사용될 것이라고 생각된다.

전남지역의 완도, 진도, 해남을 대상으로 난대상록활엽수림 복원 시 붉가시나무 종실 공급과 묘목 양성에 대한 정보 필요성에 따라 붉가시나무의 종실 생산량 및 종실 형질 특성을 조사 분석하였다. 조사 분석을 위해 표면적 1㎡의 종자 트랩을 10개(완도 8개, 해남 1개, 진도 1개) 방형구에 방형구 당 3개씩 총 30개를 설치하였다. 2013년부터 2016년 까지 매년 8월에서 12월까지 매월 말 종자 트랩 내로 낙하한 종실을 수거하였으며, 낙하 종실을 수거해 건전, 충해, 부후, 쭉정이 등으로 구분 후 종실 생산량을 산정하였다. 건전 종실의 경우 각두를 제거한 종실의 길이, 지름, 무게 등 종실 형질을 측정하였다. 조사한 종실 생산량 및 종실 형질은 연별, 임분별, 월별, 처리구별 등을 연평균 값 비교분석 을 위해 Duncan의 다중검정 등을 실시하였다. 각 방형구 내 종자 트랩 낙하 종실량은 2013년에 5~350립/3㎡, 2014년에 17~551립/3㎡, 2015년에 5~454립/3㎡, 2016년에 14~705립/3㎡로 방형구 간에 차이가 큰 것으로 나타났으며, 이는 방형구내 임목 밀도 등으로 인한 수광량의 유입차로 추정진다. 전체 연도별 종실 생산량을 ha당 산정한 결과 각각 2013년에 335,000립, 2014년에 932,000립, 2015년에 556,000립, 2016년에 1,037,000립이었으며, 2년을 주기로 다소 차이가 나타났다. 종실 생산량 증감은 임분 간 동시성을 보여 붉가시나무는 임목 개체 간 결실 풍흉 및 결실 시기의 주기성이 뚜렷한 것으로 판단된다. 9월에 가장 많은 종실이 낙하하였으나 충해종실의 피해 또한 많은 것으로 나타나 종실의 조기 낙하를 방제한다면 결실 기간을 높여 충실 종실의 대량생산이 가능할 것으로 판단된다. 지역별 연평균 종실 길이의 경우 유의성이 없었으며, 종실 지름과 종실 무게의 경우 해남 종실이 완도, 진도 종실에 비해 유의적으로 평균값이 높게 나타났다. 월별 연평균 종실 형질은 유의적 차이는 보이지 않았으며, 11월의 연평균 종실 길이, 지름, 무게가 각각 19.72㎜, 12.23㎜, 1.64g으로 8월~11월 중 최대치를 보였다.

본 연구는 제주에서 사육되고 있는 제주흑돈(제주 제래돼지 합성돈)에서 생산형질인 등지방두께, 일당증체량, 90kg도달일령과 번식형질인 총산자 수 및 생존산자수를 조사하고, 이에 대한 상가적효과와 모체환경효과를 통한 분산성분 및 유전모수를 추정하여 유전적 개량에 필요한 기초 자료를 위해 분석을 진행하였다. 생산형질 내에서 등지방두께, 일당증체량 및 90kg도달일령에 대하여 추정된 유전력은 각각 0.364, 0.271 및 0.300으로 추정되었으며, 번식형질 내에서 총산자수와 생존산자수에 대하여 추정된 유전력은 각각 0.072, 및 0.076로 유전력을 갖는 것으로 추정되었다. 생산형질에서 모체의 유전분산과 모체 공통 환경분산은 각각 0.019-0.385과 0.034-0.357로 추정되었으며, 번식형질의 경우 모체공통 환경분산은 0.348-0.459 로 추정되었다. 따라서, 제주흑돈에 대한 유전모수 추정 시 개체의 직접적인 유전효과 뿐만 아니라, 모체의 유전 또는 공통 환경효과를 고려해야 유전모수 등이 과대 추정 (over-estimate) 되는 현상을 방지 할 수 있으며, 개체들에 대한 정확한 유전 능력 평가가 이루어질 것으로 사료된다.

The Transgenic livestock can be useful for the production of disease-resistant animals, pigs for xenotranplantation, animal bioreactor for therapeutic recombinant proteins and disease model animals. Previously, conventional methods without using artificial nuclease-dependent DNA cleavage system were used to produce such transgenic livestock, but their efficiency is known to be low. In the last decade, the development of artificial nucleases such as zinc-finger necleases (ZFNs), transcription activator-like effector nucleases (TALENs) and clustered regulatory interspaced short palindromic repeat (CRISPR)/Cas has led to more efficient production of knock-out and knock-in transgenic livestock. However, production of knock-in livestock is poor. In mouse, genetically modified mice are produced by co-injecting a pair of knock-in vector, which is a donor DNA, with a artificial nuclease in a pronuclear fertilized egg, but not in livestock. Gene targeting efficiency has been increased with the use of artificial nucleases, but the knock-in efficiency is still low in livestock. In many research now, somatic cell nuclear transfer (SCNT) methods used after selection of cell transfected with artificial nuclease for production of transgenic livestock. In particular, it is necessary to develop a system capable of producing transgenic livestock more efficiently by co-injection of artificial nuclease and knock-in vectors into fertilized eggs.

이종이식 시 사람과 돼지는 면역학 적으로 일치하지 않으므로, 면역세포의 활성화 및 조직의 병변 등을 유발한다. 특히, 영장류에는 존재하지 않고 돼지의 전 조직에서 발현되는 alpha-gal 인자에 의해, 이종이식 시 alpha-gal 항원에 대한 항체의 급격한 증가로 거부반응이 유발되며 영장류를 사망에 이르게 한다. 이에, 본 연구는 alpha-gal 합성에 관여하는 효소인 alpha-galactosyltransferase를 knock out(Gal-/-)한 돼지의 세포를 기반으로, 보체의 활성을 조절하는 membrane cofactor protein(MCP)과 혈액 응고를 저해하는 thrombomodulin(TBM)의 과발현을 유도하고자 하였다. 이는, 이종이식 시 발생하는 염증반응과 혈액응고 현상을 억제하는 복합형질 전환 돼지를 개발함으로 이종이식 후의 생존성 향상에 기여하고자 하였다. 따라서 codon modification 을 통해 염기서열을 변형한 MCP cDNA 는 CAG 프로모터를 이용하여 전 조직에서 발현되도록 하였고, TBM 은 Icam2 프로모터를 통해 혈관 내피세포 특이적인 발현을 유도하였다. 제작된 벡터를 Gal-/- 돼지의 섬유아세포에 도입하고 MCP 발현 수준이 높은 세포를 선별하여 세포주를 구축하였다. 구축된 체세포를 이용하여 체세포 복제란을 생산하고 외과적 방법으로 수란 돈에 이식하였다. 체외성숙(78%) 한 난자를 복제 및 융합(58%)한 후 4 두의 대리모에 각각 약 310 개의 복제란을 이식하였다. 대리모 1 두에서 임신(25%) 및 분만(25%)에 성공하였으며, 9 두의 산자 중 6 두가 생존하고 3 두는 사망하였다. 본 연구에서 생산된 TBM 유전자가 도입된 형질전환 복제돼지는 증식과정을 통해 축군을 조성하고 향후 영장류를 활용한 이종이식 연구에 활용될 예정이다.

The purpose of this study is to develop transgenic cell line expressing targeted human granulocyte colony stimulating factor (hGCSF) and green fluorescence protein (GFP) genes as well as production of Somatic Cell Nuclear Transfer (SCNT) embryos derived from co-expressed transgenic donor cells. Constructed pPiggy-mWAP-hGCSF-EF1-GFP vector was chemically transfected into bovine fetus cells and then, only GFP expressed cells were selected as donor cells for SCNT. Cleavage and blastocyst rates of parthenogenetic, SCNT embryos using non-TG cell and hGCSF-GFP dual expressed SCNT embryos were examined (cleavage rate: 78.0±2.8 vs. 73.1±3.2 vs. 70.4±4.3%, developmental rate: 27.2 ±3.2 vs. 21.9±3.1 vs. 17.0±2.9%). Result indicated that cleavage and blastocyst rates of TG embryos were significantly lower (P<0.05) than those of parthenogenetic and non-TG embryos, respectively. In this study, we successfully produced hGCSF-GFP dual expressed SCNT embryos and cryopreserved to produce transgenic cattle for bioreactor system purpose. Further process of our research will transfer of transgenic embryos to recipients and production of hGCSF secreting cattle.

Many pronuclear stage eggs were used to generate transgenic mice (Tg) by microinjection. In this study, we used in vitro fertilized mouse eggs, followed by ultrarapid freezing to establish a simple procedure for production of Tg mice. We produced in vitro fertilized mouse eggs and cryopreserved them by ultrarapid freezing method. A total of 139 cryopreserved-thawed pronuclear eggs, of which 101 (72.6%) were survived following microinjection of chicken b-actin promoter-driven firefly improved luciferase cDNA (β-act/luc+) and were transferred into 5 recipients. All recipients became pregnant and gave birth to a total of 15 (14.8%) pups. As a control, same DNA construction (β- act/luc+) was also injected into 450 in vitro fertilized eggs, of which 338 (75.1%) were survived and then were transferred into 14 recipients. Eleven (78%) mice became pregnant and littered a total of 54 (19.1%) pups. Southern blotting analysis of Tg mice indicated that one (1/15, 6.6%) and three (3/54, 5.5%) transgenic mice were production from cryopreserved and in vitro fertilized eggs, respectively. All Tg mice produced from both eggs showed the expression of improved luciferase gene. These results indicated that efficiency of produced of Tg mice from cryopreserved eggs was comparable to that from in vitro fertilized eggs. Furthermore, it is suggested that microinjection of transgene into in vitro fertilized eggs cryopreserved by ultrarapid freezing is an easy and conveniently method for production of Tg mice.

Recently, the transgenic animal production technique is very important for the production of bio-parmaceutical as animal bio-reactor system. However, the absence of survival evaluation in vitro produced transgenic embryos has been a problem of the low productivity of transgenic animal because of absent of pre-estimate of pregnancy after transgenic embryos transferred into recipient. Therefore, this study is conducted to improve efficiency of transgenic cattle production by improving the non-surgical embryo transfer (ET) method. Transgenic bovine embryos were produced by injection of feline immunodeficiency virus enhanced green fluorescent protein (FIV-EGFP) lentiviral vector into perivitelline space of in vitro matured MІІ stage oocytes, and then in vitro fertilization (IVF) was occured. Normal IVF and EGFP expressing blastocysts were transferred into recipients. Results indicated that 2 expanded blastocysts (34.7%) transferred group showed significantly (P<0.05) higher pregnancy rate than 1 expanded blastocyst (26.8%) transferred group. In case of parity of recipient, ET to heifer (34.9%) showed significantly (P<0.05) higher pregnancy rate than ET to multiparous recipient (21.2%). However, there are no significant differences of pregnancy rate between natural induced estrus and artificial induced estrus groups. Significantly (P<0.05) higher pregnancy rate was obtained from recipient group which have normal corpus luteum with crown group (34.8%) than normal corpus luteum without crown (13.6%). Additionally, treatment of 100 μg Gn-RH injection to recipient group (38.6%) 1 day before ET significantly (P<0.05) increase pregnancy rate than non- Gn-RH injection to recipient group (38.6%). We also transferred 2 EGFP expressing expanded blastocysts to each 19 recipients, 7 recipients were pregnant and finally 5 EGFP transgenic cattle were produced under described ET condition. Therefore, our result suggested that transfer of 2 good-quality expanded blastocysts to 100 μg of Gn-RH injected recipient which have normal corpus luteum with crown is feasible to produce transgenic cattle.

BCAP 유전자를 지니는 pRB374-BCAP2와 pLip-BCAP2를 B. clausii I-52에 도입 후, 염색체 integration에 의해 구성된 pHPS9-BCAP 형질전환체(B. clausii C5)와 alkaline protease 발현율을 비교하였다. 최적화 배지(대두박 2%, 밀가루 1%, 구연산나트륨 0.5%, K2HPO4 0.4%, Na2HPO4 0.1%, NaCl 0.4%, MgSO4⋅7H2O 0.01%, FeSO4⋅7H2O 0.05%, 물엿 2.5%, 탄산나트륨 0.6%)에서 액침배양(37℃, 48 h, 650 rpm, 1 vvm) 시, pRB374- BCAP2 및 pHPS9-BCAP 형질전환체 각각은 15% 및 61% 정도 alkaline protease 생산이 증가하였다. 그러나 pLip-BCAP2 형질전환체에서는 변화가 없었다. 최고의 활성 균주인, B. clausii C5를 300 L 규모 pilot-scale 액침 배양(37℃, 30 h, 250 rpm, 1 vvm) 시, alkaline protease 생산은 105,685 U/mL로 측정되었다.

This study was conducted to analyze the transgenic efficiency and sex ratio in -1,3-galactosyltransferase (GalT) knock-out (KO) transgenic pigs according to generation. GalT KO piglets were produced by artificial insemination or natural mating. The transgenic confirmation of GalT KO was evaluated by PCR amplification using specific primers. After electrophoresis, three types of bands were detected such as 2.3 kb single band (Wild), 2.3 and 3.6kb double bands (GalT KO -/+; heterozygote), and 3.6kb single band (GalT KO -/-; homozygote). Transgenic efficiency in F1 generation was 64.5% (23/35) of GalT KO (-/+). In F2 generation, GalT KO transgenic efficiency was 36.4% (21/57, Wild), 47.5% (28/57, GalT KO -/+), and 16.1% (8/57, GalT KO -/-), respectively. Interestingly, no homozygote piglets were born in 6 deliveries among total 11 deliveries, although they were pregnant between male (M) and female (F) heterozygote. In the 5 litters including at least one GalT KO -/- piglet, the transgenic efficiency was 13.3% (2/24, Wild), 51.3% (14/24, GalT KO -/+), and 35.3% (8/24, GalT KO -/-), respectively. The sex ratio of M and F was 40:60 in and 49:51 in generation, respectively. Based on these results, GalT KO transgenic pigs have had a reproductive ability with a normal range of transgenic efficiency and sex ratio.

The overexpression of Phosphoprotein Enriched in Astrocytes (PEA15) gene is commonly found in human diabetic patients. The overexpression of this gene in skeletal muscle and fat tissues have been reported to cause insulin resistance, thereby impairing insulin stimulated glucose uptake. We introduced a gene of mouse PEA15 (mPEA15) and enhanced green fluorescent protein (EGFP) into fertilized one cell pig zygotes using microinjection, and produced a piglet that showed overexpression of mPEA15 in the muscle tissues and expression of EGFP in the ear tissues and hooves. RT-PCR RFLP, southern blot and FISH analysis showed that the tissues carried the transgene. Real-time RT-PCR and western blots demonstrated that PEA15 gene was overexpressed in the various tissues and muscle tissues, respectively. These facts suggest that expression vector system is normally expressed in the trnasgenic (TG) pigs. To use as animal diseases model for type 2 diabetes, further study is necessary to confirm whether diabetes occur in these TG pigs, especially insulin resistance.

This study was conducted to investigate the effects of donor cell treatments on the production of transgenic cloned piglets. Ear fibroblast cell obtained from NIH MHC Inbred minipig was used as control. The GalT knock-out/CD46 knock-in (GalT/CD46) transgenic cell lines were established and used as donor cells. The reconstructed GalT/CD46 embryos were surgically transferred into oviduct of naturally cycling surrogate sows (Landrace × Yorkshire) on the second day of standing estrus. Unlike control (1.2 kV/cm,, 75.4%), the fusion rate of the GalT/CD46 donor cells was significantly higher in 1.5 kV/cm, (84.5%) than that of 1.25 kV/cm, (20.2%) (p<0.01). When the number of the transferred embryos were more than 129, the pregnancy and delivery rates were increased to 13/20 (65%) and 5/20 (25%) compared to less than 100 group [1/6 (16.7%) and 0/6 (0%)], respectively. To analyze the effect of donor cell culture condition on pregnancy and delivery rates, the GalT/CD46 donor cells were cultured with DMEM or serum reduced medium. In serum reduced medium group, the pregnancy and delivery rates were improved to 8/12 (66.7%) and 5/12 (41.7%) compared to DMEM group [3/7 (42.9%) and 0/7 (0%)], respectively. In conclusion, it can be postulated that an appropriate fusion condition and culture system is essential factors to increase the efficiency of the production of transgenic cloned piglets.

We report here the production of transgenic chickens that can regulate human erythropoietin (hEPO) gene expression. The glycoprotein hormone hEPO is an essential for viability and growth of the erythrocytic progenitors. Retrovirus vector system used in this study has two features including tetracycline-controllable promoter and woodchuck hepatitis virus posttranscriptional regulator element (WPRE). The former is for to reduce the possibility of physiological disturbance due to constitutional and unregulated expression of hEPO gene in the transgenic chicken. The latter is for maximum expression of the foreign gene when we turn-on the gene expression. A replication-defective Moloney murine leukemia virus (MoMLV)-based vectors packaged with vesicular stomatitis virus G glycoprotein (VSV-G) was injected beneath the blastoderm of non-incubated chicken embryos (stage X). Out of 325 injected eggs, 28 chicks hatched after 21 days of incubation and 16 hatched chicks were found to express the hEPO gene delivered by the vector. The biological activity of the recombinant hEPO in transgenic chicken serum was comparable to its commercially available counterpart. The recombinant hEPO in transgenic chicken serum had N- and O-linked carbohydrate simillar to that produced from in vitro cultured cells transformed with hEPO gene.